tiprankstipranks
Can-Fite BioPharma (CANF)
XASE:CANF
US Market
CANF
Can-Fite BioPharma
RESEARCH TOOLSreports

Can-Fite BioPharma (CANF) Financial Statements

652 Followers

Can-Fite BioPharma Financial Overview

Can-Fite BioPharma's market cap is currently $6.84M. The company's EPS TTM is $-0.126; its P/E ratio is -0.33; Can-Fite BioPharma is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 408.21K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Gross Profit$ 384.02K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Operating Income$ -10.03M$ -8.13M$ -8.20M$ -10.10M$ -12.84M
EBITDA$ -10.00M$ -8.12M$ -8.18M$ -10.08M$ -12.83M
Net Income$ -9.91M$ -7.88M$ -7.63M$ -10.17M$ -12.60M
Balance Sheet
Cash & Short-Term Investments$ 8.54M$ 7.89M$ 8.92M$ 7.98M$ 19.14M
Total Assets$ 9.51M$ 9.12M$ 9.99M$ 9.28M$ 20.25M
Total Debt$ 71.00K$ 104.00K$ 40.00K$ 62.00K$ 124.00K
Net Debt$ -5.46M$ -4.72M$ -4.24M$ -2.92M$ -4.27M
Total Liabilities$ 3.92M$ 3.68M$ 3.75M$ 4.81M$ 5.87M
Stockholders' Equity$ 5.59M$ 5.44M$ 6.24M$ 4.47M$ 14.38M
Cash Flow
Free Cash Flow$ -9.02M$ -7.64M$ -8.44M$ -10.81M$ -9.87M
Operating Cash Flow$ -9.02M$ -7.64M$ -8.44M$ -10.80M$ -9.86M
Investing Cash Flow$ -2.02K$ 1.50M$ 498.00K$ 9.50M$ -14.51M
Financing Cash Flow$ 9.72M$ 6.71M$ 9.14M$ 0.00$ 20.46M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

Income Statement >

Can-Fite BioPharma Debt to Assets

Balance Sheet >

Can-Fite BioPharma Cash Flow

Cash Flow >

Can-Fite BioPharma Forecast EPS vs Actual EPS

Earnings >